anti-CD133-CAR vector-transduced allogeneic T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-010228
A preparation of allogeneic peripheral blood T lymphocytes (PBTL) that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the chimeric CD (cluster of differentiation) 133 antigen receptor, with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD133-CAR vector-transduced allogeneic T lymphocytes specifically recognize and kill CD133-expressing tumor cells. CD133, a tumor associated antigen (TAA), is overexpressed on a variety of tumor cell types.
| Identifier | MLC-T-ONC-010228 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | allogeneic CART133; allogeneic anti-CD133 CAR T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010228",
"term": "anti-CD133-CAR vector-transduced allogeneic T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of allogeneic peripheral blood T lymphocytes (PBTL) that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the chimeric CD (cluster of differentiation) 133 antigen receptor, with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD133-CAR vector-transduced allogeneic T lymphocytes specifically recognize and kill CD133-expressing tumor cells. CD133, a tumor associated antigen (TAA), is overexpressed on a variety of tumor cell types.",
"synonyms": [
"allogeneic CART133",
"allogeneic anti-CD133 CAR T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-cd133-car-vector-transduced-allogeneic-t-lymphocytes/"
}
Record 1,313 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.